FloridaMarijuana.net

JULY 8, 2018

According to the MAPS website they are “working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). Food and Drug Administration.

Strains 190

Strains Indica Hybrid Research and Development 190

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. While there is no date yet on when the formal decision from the DEA will be released, it could be as soon as a few weeks from now.

DEA 104

DEA Chronic Pain Treatment Therapy 104

Cannabis Law Report

JULY 13, 2021

The California legislation that would decriminalize some psychedelic substances under state law, Senate Bill 519, was approved in a 5-3 vote by the State Assembly’s Public Safety Committee in a June 29th hearing. This vote marks the bill’s first hearing in the Assembly after passing in a 21-16 vote by the State Senate on June 1.

Decriminalization 105

Decriminalization Legislation DEA Safety 105

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Canna Law Blog

MARCH 4, 2020

And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Therapy 107

Therapy Legalization Chronic Pain DEA 107

Cannabis Law Report

JULY 20, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

The Blunt Truth

MAY 15, 2020

The National Cannabis Industry Association would like to get the DEA out of research entirely, and state-level research could be a substitute for the federal program. The group promises to follow safety protocols, so they can muster the support they need, without risking anyone’s health. No word yet on any change in policy.

Banking 106

Banking Research and Development Programs Advocacy 106

Illinois News Joint

NOVEMBER 6, 2024

percent have been interpreted by the Drug Enforcement Administration (DEA) as federally legal hemp. HB5309 will empower urban farmers, support small businesses, protect public safety, and position Illinois as a national leader.” Say that Delta-8 is safe despite never being used by humans until 2021 and no safety data exists on it.

Hemp 78

Hemp Agriculture THC DEA 78

Cannabis Law Report

JULY 30, 2021

With hemp already federally legal, a primary policy issue is how marijuana and hemp—two varieties of the cannabis plant—would be distinguished under a federal regulatory regime. We strongly encourage participation in this important opportunity to shape federal cannabis policy. Distinction between Cannabis and Hemp Under the CAOA.

Hemp 105

Hemp Law Seed-To-Sale Food 105

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 81

Law Research and Development Therapy DEA 81

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Dykema (Cannabis Law Blog)

OCTOBER 6, 2023

From a policy standpoint, there are pros and cons to this approach. On the other hand, with no laws or regulations around the production of the plants and fungi, there is no framework for safety or quality control (i.e., On the one hand, this kind of decrim bill arguably democratized access to psychedelics.

Consumption 58

Consumption DEA Decriminalization Access 58

Veriheal

AUGUST 23, 2023

A disputable new social media drug reporting bill believes that social media companies should screen client posts and report any drug-related exercises to the DEA. It is critical that the perspectives of groups who are most affected by drug enforcement policies are centered in these conversations around reform.

Media 52

Media DEA Advocacy Legislation 52

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Cannabis Law Report

JANUARY 14, 2020

Senior Policy Advisor, Diversion Control Division. Additionally, it would open up medical marijuana policies with “directives to conduct research on the impact of marijuana on the brain, the efficacy of medical marijuana, identification of additional medical benefits and uses of cannabis, and support highway safety research.”.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

FEBRUARY 25, 2019

There are remaining concerns as to the state health department’s treatment policy towards these products as well. Ohio, Texas and Maine have also experienced adverse enforcement activities, and other states such as North Carolina are threatening the same.

CBD 71

CBD Food Compliance Compliance 71

Cannabis Law Report

JULY 27, 2022

As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S.

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

SEPTEMBER 29, 2021

The membership subsequently met with the USDA’s new Hemp Work Group, and White House officials that serve the President on agriculture and drug control policy. Senators) who joined the group in a spirited, interactive discussion on hemp public policy. The national media took notice of some of the highlights: Rep.

Hemp 52

Hemp Banking Legislation Policy 52

SpeedWeed

APRIL 27, 2021

“But my contacts at the American Herbal Products Association, as well as the DEA (Drug Enforcement Administration) and the American Western Hemp Professionals, and the U.S. Anecdotally, we understand that the DEA is actively monitoring the proliferation of delta-8 THC products.”. Andrea Golan, cannabis industry lawyer.

Legalization 52

Legalization DEA Supply Chain Hemp 52

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. We are not going to attempt to tackle the myriad policy issues of this alternative, but we do have some observations.

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

JULY 2, 2019

Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.

Compliance 40

Compliance Compliance Programs CBD 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

MAY 24, 2022

Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions. The criminalization of marijuana was the result of racially motivated policies, such as the Marijuana Tax Act of 1937. The Tax Act was litigated in Leary v.

DEA 52

DEA History Medicine Marijuana 52

SpeedWeed

JUNE 8, 2021

Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S.

Topical 40

Topical THC Agriculture Cannabinoids 40

Cannabis Law Report

JUNE 8, 2021

As the largest cannabis nonprofit in the state, it provides a network of farmers, processors, manufacturers, retailers, distributors and service providers with vital industry news, valuable business-to-business opportunities and influence to shape the regulatory and public policy decisions.

Hemp 78

Hemp Seed-To-Sale Food Research and Development 78

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. Senators Cory Booker, D-N.J.,

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

MAY 25, 2022

The court also considered Boyd Street’s counterarguments that (1) DEA has interpreted the 2018 Farm Bill as inapplicable to delta-8 THC due to its method of manufacture and (2) Congress never intended for the Act to legalize any psychoactive substance. as opposed to delta-8 THC or total THC (i.e., The Implications.

THC 52

THC Legalization Hemp Concentrates 52

Cannabis Law Report

MAY 1, 2019

8 In January of this year, Attorney General Jeff Sessions rescinded an Obama-era policy which had de-prioritized federal prosecution of those involved in the cannabis industry in states which had legalized medical or recreational cannabis. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

AUGUST 6, 2021

Drug Enforcement Administration (the “DEA”), the U.S. state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Food and Drug Administration (the “FDA”), the U.S. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

Meadow

JULY 13, 2018

Isa Perez (Head of Business Development at Meadow) moderates the Update from Local Regulators Panel with Joe Devlin (Sacramento Cannabis Policy and Enforcement), Cat Packer (Los Angeles Department of Cannabis Regulation), and Nicole Elliot ( San Francisco Office of Cannabis). Photo Credit: Kandid Kush.

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40